References

Cancer statistics, 2020

2020 · External reference

NIR-II driven plasmon-enhanced catalysis for a timely supply of oxygen to overcome hypoxia-induced radiotherapy tolerance

10.1002/anie.201906758 · 2019 · External reference

Fluorescence discrimination of cancer from inflammation by molecular response to COX-2 enzymes

10.1021/ja4085308 · 2013 · External reference

Nanotechnology: breaking the current treatment limits of lung cancer

10.1002/adhm.202100078 · 2021 · External reference

Intra/extracellular lactic acid exhaustion for synergistic metabolic therapy and immunotherapy of tumors

10.1002/adma.201904639 · 2019 · External reference

Links between inflammation and postoperative cancer recurrence

10.3390/jcm10020228 · 2021 · External reference

Targeting strategies for tissue-specific drug delivery

10.1016/j.cell.2020.02.001 · 2020 · External reference

Nattokinase-mediated regulation of tumor physical microenvironment to enhance chemotherapy, radiotherapy, and CAR-T therapy of solid tumor

10.1021/acsnano.2c12463 · 2023 · External reference

Correction to: any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

10.1186/s13287-021-02523-2 · 2021 · External reference

HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells

10.1038/s41590-020-0593-9 · 2020 · External reference

Natural killer cells in cancer biology and therapy

10.1186/s12943-020-01238-x · 2020 · External reference

Exploring the NK cell platform for cancer immunotherapy

10.1038/s41571-020-0426-7 · 2021 · External reference

Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated blood and cord blood-derived NK cells facilitates CAR-like responses against CD30+ malignancies

10.1158/1078-0432.ccr-21-0164 · 2021 · External reference

Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-cell lymphoma therapy

10.1002/anie.202005934 · 2021 · External reference

Conscription of immune cells by light-activatable silencing NK-derived exosome (LASNEO) for synergetic tumor eradication

2022 · External reference

Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders

10.1038/s41573-022-00413-7 · 2022 · External reference

Ex vivo-expanded natural killer cells derived from long-term cryopreserved cord blood are cytotoxic against primary breast cancer cells

10.1097/cji.0000000000000192 · 2018 · External reference

Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis

10.1016/j.cell.2022.03.030 · 2022 · External reference

Selenium-containing nanoparticles synergistically enhance Pemetrexed&NK cell-based chemoimmunotherapy

10.1016/j.biomaterials.2021.121321 · 2022 · External reference

Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering

10.1016/j.coi.2018.03.013 · 2018 · External reference

Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy

10.1186/s40425-019-0612-2 · 2019 · External reference

Metabolic reprograming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity

10.1016/j.stem.2020.05.008 · 2020 · External reference

Harnessing natural killer cells to develop next-generation cellular immunotherapy

2022 · External reference

Aptamer-engineered natural killer cells for cell-specific adaptive immunotherapy

2019 · External reference

CD38-specific CAR integrated into CD38 locus driven by different promoters causes distinct antitumor activities of T and NK cells

10.1002/advs.202207394 · 2023 · External reference

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors

10.1016/j.isci.2021.102619 · 2021 · External reference

Directly reprogrammed natural killer cells for cancer immunotherapy

10.1038/s41551-021-00768-z · 2021 · External reference

Nanobody-engineered natural killer cell conjugates for solid tumor adoptive immunotherapy

2021 · External reference

Cell-type-specific, aptamer-functionalized agents for targeted disease therapy

10.1038/mtna.2014.21 · 2014 · External reference

Aptamer inhibits tumor growth by leveraging cellular proteasomal degradation system to degrade c-met in mice

2023 · External reference

High-affinity dimeric aptamers enable the rapid electrochemical detection of wild-type and B.1.1.7 SARS-CoV-2 in unprocessed saliva

10.1002/anie.202110819 · 2021 · External reference

Aptamers evolved from live cells as effective molecular probes for cancer study

10.1073/pnas.0602615103 · 2006 · External reference

Nucleic acid aptamers for molecular diagnostics and therapeutics: advances and perspectives

10.1002/anie.202003563 · 2021 · External reference

Engineering aptamers with selectively enhanced biostability in the tumor microenvironment

10.1002/anie.202201220 · 2022 · External reference

Equipping natural killer cells with specific targeting and checkpoint blocking aptamers for enhanced adoptive immunotherapy in solid tumors

10.1002/anie.202002145 · 2020 · External reference

Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells

10.1016/j.biomaterials.2021.121259 · 2022 · External reference

Artificial engineered natural killer cells combined with antiheat endurance as a powerful strategy for enhancing photothermal-immunotherapy efficiency of solid tumors

10.1002/smll.201970228 · 2019 · External reference

Aptamer-based logic computing reaction on living cells to enable non-antibody immune checkpoint blockade therapy

10.1021/jacs.1c02016 · 2021 · External reference

Mapping molecules in scanning far-field fluorescence nanoscopy

10.1038/ncomms8977 · 2015 · External reference

Superlarge, rigidified DNA tetrahedron with a Y-shaped backbone for organizing biomolecules spatially and maintaining their full bioactivity

10.1021/acsnano.3c13189 · 2024 · External reference

Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation

10.1021/nn507494p · 2015 · External reference

Membrane-anchored DNA nanojunctions enable closer antigen-presenting cell-T-cell contact in elevated T-cell receptor triggering

10.1038/s41565-023-01333-2 · 2023 · External reference

Cell-membrane-anchored DNA nanoplatform for programming cellular interactions

10.1021/jacs.9b04725 · 2019 · External reference

DNA-based dynamic mimicry of membrane proteins for programming adaptive cellular interactions

10.1021/jacs.0c11245 · 2021 · External reference

Engineering a 3D DNA-logic gate nanomachine for bispecific recognition and computing on target cell surfaces

10.1021/jacs.8b04319 · 2018 · External reference

Barcoded DNA nanostructures for the multiplexed profiling of subcellular protein distribution

10.1038/s41551-019-0417-0 · 2019 · External reference

Nature-inspired DNA nanosensor for real-time in situ detection of mRNA in living cells

10.1021/acsnano.5b01954 · 2015 · External reference

Quantum dot-loaded monofunctionalized DNA icosahedra for single-particle tracking of endocytic pathways

10.1038/nnano.2016.150 · 2016 · External reference

Engineering a second-order DNA logic-gated nanorobot to sense and release on live cell membranes for multiplexed diagnosis and synergistic therapy

10.1002/anie.202103993 · 2021 · External reference

Reconfigurable three-dimensional DNA nanostructures for the construction of intracellular logic sensors

10.1002/anie.201202356 · 2012 · External reference

Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy

10.1093/nar/gkaa683 · 2020 · External reference

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

10.1038/nnano.2012.73 · 2012 · External reference

Outward movement of targeting ligands from a built-in reserve pool in nuclease-resistant 3D hierarchical DNA nanocluster for in vivo high-precision cancer therapy

10.1002/advs.202203698 · 2022 · External reference

Y-shaped backbone-rigidified DNA tiles for the construction of supersized nondeformable tetrahedrons for precise cancer therapies

10.1021/acs.analchem.3c03923 · 2024 · External reference

Programmable and multifunctional DNA-based materials for biomedical applications

2018 · External reference

Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment

10.1038/s41596-020-0355-z · 2020 · External reference

DNA tetrahedral nanostructures for the biomedical application and spatial orientation of biomolecules

2024 · External reference

Nuclease resistance of DNA nanostructures

10.1038/s41570-021-00251-y · 2021 · External reference

Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells

10.1080/20013078.2017.1294368 · 2017 · External reference

Aptamer display on diverse DNA polyhedron supports

2018 · External reference

A DNA nanostructure-based biomolecular probe carrier platform for electrochemical biosensing

10.1002/adma.201002767 · 2010 · External reference

A DNA nanostructure for the functional assembly of chemical groups with tunable stoichiometry and defined nanoscale geometry

10.1002/anie.200804264 · 2009 · External reference

Valency-controlled framework nucleic acid signal amplifiers

10.1002/anie.201802701 · 2018 · External reference

Multiple-armed tetrahedral DNA nanostructures for tumor-targeting, dual-modality in vivo imaging

10.1021/acsami.5b10792 · 2016 · External reference

DNA-based nanomedicine with targeting and enhancement of therapeutic efficacy of breast cancer cells

10.1021/acsami.9b03449 · 2019 · External reference

Collapse of DNA tetrahedron nanostructure for “off-on” fluorescence detection of DNA methyltransferase activity

10.1021/acsami.7b13551 · 2017 · External reference

In vivo imaging of membrane-associated glycans in developing zebrafish

10.1126/science.1155106 · 2008 · External reference

Tissue-based metabolic labeling of polysialic acids in living primary hippocampal neurons

10.1073/pnas.1419683112 · 2015 · External reference

Nanoengineered CAR-T biohybrids for solid tumor immunotherapy with microenvironment photothermal-remodeling strategy

2021 · External reference

Development of a cancer vaccine using in vivo click-chemistry-mediated active lymph node accumulation for improved immunotherapy

10.1002/adma.202006007 · 2021 · External reference

Mild reduction of the cancer cell surface as an anti-invasion treatment

10.1021/acsami.8b12566 · 2018 · External reference

General and facile coating of single cells via mild reduction

10.1021/jacs.7b08440 · 2018 · External reference

Encapsulation of individual living cells with enzyme responsive polymer nanoshell

10.1016/j.biomaterials.2019.01.029 · 2019 · External reference

Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs

2026 · External reference

Covalent modification of biomolecules through maleimide-based labeling strategies

10.1021/acs.bioconjchem.8b00252 · 2018 · External reference

A protein-binding molecular photothermal agent for tumor ablation

10.1002/anie.202101009 · 2021 · External reference

Long-term stabilization of maleimide-thiol conjugates

10.1021/bc5005262 · 2015 · External reference

Simple and universal signal labeling of cell surface for amplified detection of cancer cells via mild reduction

10.1016/j.bios.2019.111714 · 2019 · External reference

A single-step chemoenzymatic reaction for the construction of antibody-cell conjugates

10.1021/acscentsci.8b00552 · 2018 · External reference

Adhesive AuNP tape-mediated hierarchical assembly of multicenter DNA nanocomplexes for tumor cell nucleus-targeted staged drug delivery in vivo

10.1016/j.nantod.2022.101687 · 2022 · External reference

Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect

10.1039/d0tb01668c · 2021 · External reference

Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression

10.1016/j.jconrel.2022.06.039 · 2022 · External reference

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

10.1038/s41571-021-00473-5 · 2021 · External reference

Enrichment and sensing tumor cells by embedded immunomodulatory DNA hydrogel to inhibit postoperative tumor recurrence

10.1038/s41467-023-40085-4 · 2023 · External reference

Biodegradable manganese-doped calcium phosphate nanotheranostics for traceable cascade reaction-enhanced anti-tumor therapy

10.1021/acsnano.9b05836 · 2019 · External reference

Bead-string-shaped DNA nanowires with intrinsic structural advantages and their potential for biomedical applications

10.1021/acsami.9b16249 · 2020 · External reference

Metal-DNA nanocomplexes enhance chemo-dynamic therapy by inhibiting autophagy-mediated resistance

10.1002/anie.202307020 · 2023 · External reference

A self-assembled platform based on branched DNA for sgRNA/Cas9/antisense delivery

10.1021/jacs.9b09043 · 2019 · External reference

Endogenous mRNA triggered DNA-Au nanomachine for in situ imaging and targeted multimodal synergistic cancer therapy

10.1002/ange.202012801 · 2021 · External reference

A triple combination strategy for nasopharyngeal carcinoma: aptamer-guided liposomal chemotherapy, engineered NK cells, and Fc-enhanced PD-L1 antibody therapy

10.1016/j.apsb.2025.10.007 · 2026 · External reference

Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53

10.1016/s1357-2725(00)00080-7 · 2001 · External reference